newsfilter
← Latest News
GlobeNewswire·

Lisata Therapeutics Announces Completion of Enrollment in the CENDIFOX Trial

BASKING RIDGE, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (NASDAQ:LSTA) ("Lisata"), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid